Marriage of Albumin–Gadolinium Complexes and MoS₂ Nanoflakes as Cancer Theranostics for Dual-Modality Magnetic Resonance/Photoacoustic Imaging and Photothermal Therapy

The construction of safe and stable theranostics is beneficial to realize simultaneous cancer diagnosis and treatment. In this study, bovine serum albumin–gadolinium (BSA–Gd) complexes and MoS 2 nanoflakes (MoS 2 –Gd–BSA) were successfully married as cancer theranostics for dual-modality magnetic resonance (MR)/photoacoustic (PA) imaging and photothermal therapy (PTT). BSA–Gd complexes were prepared by the biomineralization method and then conjugated with MoS 2 nanoflakes via an amide bond. The as-prepared MoS 2 –Gd–BSA possessed a good photostability and photothermal effect. The cytotoxicity assessment and hemolysis assay suggested the excellent biocompatibility of MoS 2 –Gd–BSA. Meanwhile, MoS 2 –Gd–BSA could not only achieve in vivo MR/PA dual-modality imaging of xenograft tumors, but also effectively kill cancer cells in vitro and ablate the xenograft tumors in vivo upon 808 nm laser illumination. The biodistribution and histological evaluations indicated the negligible toxicity of MoS 2 –Gd–BSA both in vitro and in vivo. Thus, our results substantiated the potential of MoS 2 –Gd–BSA for cancer theranostics.